Tag: curaleaf
-
Rua Bioscience Reports 53% Revenue Growth but Warns Working Capital Is "Immediate Constraint"
Rua Bioscience posts $2.9m total revenue, up 53%, and a narrowing operating loss at its 2026 annual meeting, but says funding inventory for its $10m-plus UK Curaleaf deal is now its biggest challenge.
BusinessHealthUnited KingdomCanadaEconomyFinancial MarketsMedical ScienceTradeEurope Rua BioscienceAnna StovePaul Naskemedicinal cannabisCuraleafannual shareholders meeting